Seer (SEER) Cash from Financing Activities (2020 - 2026)
Seer (SEER) recorded quarterly Cash from Financing Activities of -$2.6 million in Q1 2026, down 1923.78% quarter-over-quarter from $143000.0 in Q4 2025, and down 73.64% on a YoY basis from -$9.9 million in Q1 2025.
Seer (SEER) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Seer's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 73.64% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$11.7 million (up 10.18% YoY), while the FY2025 annual figure was -$10.6 million, up 8.06% from the prior year.
- Cash from Financing Activities was -$2.6 million for Q1 2026 at Seer, down from $143000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.1 million in Q4 2022 to a low of -$7.2 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged -$1.3 million across 5 years, with a median of $29000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 310.71% in 2022, then sank 23803.57% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $2.1 million in 2022, then slumped by 91.36% to $182000.0 in 2023, then tumbled by 791.21% to -$1.3 million in 2024, then jumped by 111.37% to $143000.0 in 2025, then plunged by 1923.78% to -$2.6 million in 2026.
- The last three Cash from Financing Activities figures came in at -$2.6 million (Q1 2026), $143000.0 (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 85,464.43 |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.61 Mn |
| Mar 31, 2026 | -2.61 Mn |
| Dec 31, 2025 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | -1.99 Mn |
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | -7.22 Mn |
| Jun 30, 2025 | -7.22 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | -6.64 Mn |
| Sep 30, 2024 | -6.64 Mn |
| Jun 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | -3.60 Mn |
| Dec 31, 2023 | 182,000.00 |
| Dec 31, 2023 | 182,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Sep 30, 2023 | 28,000.00 |